Postischemic microvasculopathy and endothelial progenitor cell-based therapy in ischemic AKI: update and perspectives

被引:17
|
作者
Patschan, D. [1 ]
Kribben, A. [2 ]
Mueller, G. A. [1 ]
机构
[1] Univ Gottingen, Univ Hosp Gottingen, Clin Nephrol & Rheumatol, Gottingen, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany
关键词
acute kidney injury; EPCs; microvasculopathy; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; MESENCHYMAL STEM-CELLS; CISPLATIN-INDUCED NEPHROTOXICITY; REPERFUSION INJURY; MITOCHONDRIAL INJURY; BARRIER FUNCTION; PROXIMAL TUBULE; POTENTIAL ROLE; RAT MODEL;
D O I
10.1152/ajprenal.00232.2016
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Acute kidney injury (AKI) dramatically increases mortality of hospitalized patients. Incidences have been increased in recent years. The most frequent cause is transient renal hypoperfusion or ischemia which induces significant tubular cell dysfunction/damage. In addition, two further events take place: interstitial inflammation and microvasculopathy (MV). The latter evolves within minutes to hours postischemia and may result in permanent deterioration of the peritubular capillary network, ultimately increasing the risk for chronic kidney disease (CKD) in the long term. In recent years, our understanding of the molecular/cellular processes responsible for acute and sustained microvasculopathy has increasingly been expanded. The methodical approaches for visualizing impaired peritubular blood flow and increased vascular permeability have been optimized, even allowing the depiction of tissue abnormalities in a three-dimensional manner. In addition, endothelial dysfunction, a hallmark of MV, has increasingly been recognized as an inductor of both vascular malfunction and interstitial inflammation. In this regard, so-called regulated necrosis of the endothelium could potentially play a role in postischemic inflammation. Endothelial progenitor cells (EPCs), represented by at least two major subpopulations, have been shown to promote vascular repair in experimental AKI, not only in the short but also in the long term. The discussion about the true biology of the cells continues. It has been proposed that early EPCs are most likely myelomonocytic in nature, and thus they may simply be termed proangiogenic cells (PACs). Nevertheless, they reliably protect certain types of tissues/organs from ischemia-induced damage, mostly by modulating the perivascular microenvironment in an indirect manner. The aim of the present review is to summarize the current knowledge on postischemic MV and EPC-mediated renal repair.
引用
收藏
页码:F382 / F394
页数:13
相关论文
共 50 条
  • [31] Progress of stem/progenitor cell-based therapy for retinal degeneration
    Zhimin Tang
    Yi Zhang
    Yuyao Wang
    Dandan Zhang
    Bingqiao Shen
    Min Luo
    Ping Gu
    Journal of Translational Medicine, 15
  • [32] Advanced Functional Materials and Cell-Based Therapies for the Treatment of Ischemic Stroke and Postischemic Stroke Effects
    Tapeinos, Christos
    Larranaga, Aitor
    Tomatis, Francesca
    Bizeau, Joelle
    Marino, Attilio
    Battaglini, Matteo
    Pandit, Abhay
    Ciofani, Gianni
    ADVANCED FUNCTIONAL MATERIALS, 2020, 30 (01)
  • [33] Gene therapy of endothelial progenitor cell for vascular development in severe ischemic disease
    Asahara, T
    Iwaguro, H
    Kalka, C
    Masuda, H
    Hayashi, S
    Silver, M
    CIRCULATION, 1999, 100 (18) : 481 - 481
  • [34] Generation of Pulmonary Endothelial Progenitor Cells for Cell-based Therapy Using Interspecies Mouse-Rat Chimeras
    Wang, Guolun
    Wen, Bingqiang
    Ren, Xiaomeng
    Li, Enhong
    Zhang, Yufang
    Guo, Minzhe
    Xu, Yan
    Whitsett, Jeffrey A.
    Kalin, Tanya, V
    Kalinichenko, Vladimir V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (03) : 326 - 338
  • [35] Update on mesenchymal stem cell-based therapy in lupus and scleroderma
    Cras, Audrey
    Farge, Dominique
    Carmoi, Thierry
    Lataillade, Jean-Jacques
    Wang, Dan Dan
    Sun, Lingyun
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [36] Update on mesenchymal stem cell-based therapy in lupus and scleroderma
    Audrey Cras
    Dominique Farge
    Thierry Carmoi
    Jean-Jacques Lataillade
    Dan Dan Wang
    Lingyun Sun
    Arthritis Research & Therapy, 17
  • [37] Endothelial progenitor cells: the promise of cell-based therapies for acute lung injury
    Mei Mao
    Xilin Xu
    Yong Zhang
    Bo Zhang
    Zu-hong Fu
    Inflammation Research, 2013, 62 : 3 - 8
  • [38] Endothelial progenitor cell-based delivery of TrpRS fragments inhibits retinal angiogenesis
    Otani, A
    Kinder, K
    Ewalt, K
    Silke, B
    Otero, F
    Schimmel, P
    Friedlander, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1028 - U1028
  • [39] Endothelial Colony Forming Cells (ECFCs) in murine AKI – implications for future cell-based therapies
    D. Patschan
    K. Schwarze
    B. Tampe
    M. Zeisberg
    S. Patschan
    G. A. Müller
    BMC Nephrology, 18
  • [40] Endothelial Colony Forming Cells (ECFCs) in murine AKI - implications for future cell-based therapies
    Patschan, D.
    Schwarze, K.
    Tampe, B.
    Zeisberg, M.
    Patschan, S.
    Mueller, G. A.
    BMC NEPHROLOGY, 2017, 18 : 1 - 12